Jun 18, 2024, 06:04
Joshua Zeidner: Important results from ENHANCE-3 by Naval Daver
Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X:
“Disappointing but important results from ENHANCE-3 by Naval Daver. We need to learn from these negative trials to design the optimal studies, protocols, and dosing schedules in the future. Still unclear why there were more infection-related deaths with Magrolimab. ”
Source: Joshua Zeidner/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 12:34
Nov 20, 2024, 11:34
Nov 20, 2024, 11:23
Nov 20, 2024, 10:18